Investigating the additive effects of Alzheimer’s disease biomarker staging and subjective cognitive decline in the prediction of clinical progression

SCD provides incremental information for the identification of individuals at high risk of imminent cognitive decline beyond a biomarker-based classification of AD pathology. In cognitively unimpaired individuals, the clinical stage should be taken into account additionally to AD biomarkers for an improved prediction of the time until clinical progression.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.091377
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Investigating the additive effects of Alzheimer’s disease biomarker staging and subjective cognitive decline in the prediction of clinical progression

Emrah Düzel, Jens Wiltfang, Robert Perneczky, Annika Spottke et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Investigating the additive effects of Alzheimer’s disease biomarker staging and subjective cognitive decline in the prediction of clinical progression

Emrah Düzel, Jens Wiltfang, Robert Perneczky, Annika Spottke, Oliver Peters, Stefan Johannes Teipel, Elizabeth Kuhn, Matthias Schmid, Luca Kleineidam, Michael Wagner, Josef Priller, Frank Jessen, Julian Hellmann‐Regen, Anja Schneider, Michael T. Heneka, Melina Stark, Katharina Bürger, Christoph Laske
article en

Abstract

SCD provides incremental information for the identification of individuals at high risk of imminent cognitive decline beyond a biomarker-based classification of AD pathology. In cognitively unimpaired individuals, the clinical stage should be taken into account additionally to AD biomarkers for an improved prediction of the time until clinical progression.

Alzheimer s & DementiaVol. 20(S3)
University of Bonn (DE), University of Cologne (DE), University of Luxembourg (LU), University Hospital Bonn (DE), German Center for Neurodegenerative Diseases (DE), LMU Klinikum (DE), Humboldt-Universität zu Berlin (DE), Zimmer Biomet (Germany) (DE), Munich Cluster for Systems Neurology (DE), UK Dementia Research Institute (GB), Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE), Hertie Institute for Clinical Brain Research (DE), University of Rostock (DE), University of Aveiro (PT), Technical University of Munich (DE), University of Göttingen (DE), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE), Otto-von-Guericke-Universität Magdeburg (DE), University of Edinburgh (GB)
Openalex Percentile: Top 66%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.